Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Intervalo de año de publicación
1.
Value Health Reg Issues ; 32: 88-94, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-36152397

RESUMEN

OBJECTIVES: This study aimed to calculate the healthcare resource utilization and direct medical costs in patients with 2 subtypes of axial spondyloarthritis (axSpA) in a rheumatic care center in Colombia. METHODS: This is a retrospective cost-of-illness study. Patients with at least 1 medical consultation associated with an axSpA diagnosis between October 2018 and October 2019 were identified. Patients were classified as having radiographic (r-axSpA) or nonradiographic axSpA (nr-axSpA). Direct medical costs were calculated in Colombian pesos and expressed in American dollars using an exchange rate of 3263 Colombian pesos = 1 US dollar ($). Predictors of total direct costs were identified using a generalized linear model with gamma distribution and log-link. RESULTS: A total of 162 patients with a mean age of 49.6 years (± 13.7) were included in the study. Among these, 147 (90.7%) were considered as having r-axSpA and 15 (9.3%) nr-axSpA, with mean costs of $6600 (± 6203) and $843 (± 1135), respectively (P < .001). The total direct mean cost was calculated at $6067 (± 6144) per patient. Medication costs were the main driver of total costs (97.6%, $5921), with biologic disease-modifying antirheumatic drugs accounting for nearly 92.0% ($5582) of these costs. Rheumatologist (100%) and physiatrist (64.2%) visits were the most frequently used medical service. CONCLUSIONS: The economic burden associated with axSpA in the Colombian setting is substantial. There is a significant difference in direct medical costs between the r-axSpA and the nr-axSpA. Health policies aimed at the comprehensive management of nr-axSpA would have an important role in the reduction of the associated direct medical costs.


Asunto(s)
Espondiloartritis Axial , Espondiloartritis , Espondilitis Anquilosante , Humanos , Persona de Mediana Edad , Espondiloartritis/diagnóstico , Espondiloartritis/tratamiento farmacológico , Espondilitis Anquilosante/diagnóstico , Espondilitis Anquilosante/tratamiento farmacológico , Colombia , Estudios Retrospectivos , Atención a la Salud
2.
Psoriasis (Auckl) ; 11: 31-39, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33777724

RESUMEN

OBJECTIVE: To estimate the frequency of health care resource utilization and direct medical costs associated with Psoriatic Arthritis (PsA) in a rheumatic care center in Colombia. METHODS: A retrospective prevalence-based cost of illness study under the Colombian health care system perspective was conducted. We analyzed the frequency of health care resource utilization and estimated direct medical costs using anonymized medical records of adult patients (≥18 years) diagnosed with PsA at a rheumatology care center in Bogotá, Colombia. Patients were required to have at least one medical visit linked to a PsA diagnosis (ICD-10 L40.5) between October 2018 and October 2019 and a previous diagnose by the CASPAR criteria. Data on hospitalization episodes was not available. Direct medical costs were estimated in Colombian pesos (COP) and reported in US dollars (USD) using an exchange rate of 1USD = 3263.4 COP. A multivariate generalized linear model was used for identifying potential cost predictors. RESULTS: A sample of 83 patients was obtained. Of these, 54.2% were women and had a mean (SD) age of 58.7 (12) years at baseline. On average, they had 2.2 and 3.8 medical visits to the dermatologist and rheumatologist in the study period. The total direct medical cost was estimated at 410,985 US Dollars. Medical visits, therapies, laboratory and imaging represented 3.2% of total expenses and medications the remaining 96.8%. Patients receiving conventional DMARDs (cDMARDs) had an associated mean cost of 1020.1 USD (CI 701.4-1338.8) in a year. Among patients treated with cDMARDs and biological DMARDs (bDMARDs) the mean cost increase to 8113.9 USD (SD 5182.0-95% CI 6575.1-9652.8). CONCLUSION: A patient under biological therapy can increase their annual cost by 7.9 times the cost of a patient in conventional therapy. This provided updated knowledge on the direct medical costs, from the provision of a rheumatic care center service, to support epidemiologic or pharmacovigilance models.

3.
Rev. cienc. salud (Bogotá) ; 17(2): 259-275, may.-ago. 2019. tab, graf
Artículo en Español | LILACS, COLNAL | ID: biblio-1013873

RESUMEN

Resumen Objetivo : determinar los factores asociados con estancias prolongadas en uci neonatal. Materiales y métodos : estudio de tipo retrospectivo, de corte transversal, descriptivo y analítico a partir de los Registros Individuales de Prestación de Servicios (RIPS) y la facturación de una Empresa Prestadora de Servicios de Salud (EPS) de Colombia. Se estimó un modelo logístico binomial tomando como variable dependiente estancias prolongadas. Resultados : la mediana de la duración en estancia en uci de los 947 neonatos incluidos en el análisis fue de 3 días y una estancia promedio de 4.8 días (amplitud intercuartílica de 1-5 días). Respecto a los determinantes, la edad gestacional, el peso al nacer y la edad de la madre mantienen una relación inversa con la probabilidad de generar días estancias, residir en zonas urbanas y contar con un buen control prenatal se convierten en factores protectores. Conclusión : el control prenatal es una intervención eficiente y efectiva para la gestión del riesgo de la salud, así como disminuir los embarazos en las mujeres jóvenes (<18 años) y mayores (>35 años) cumplirían un papel fundamental en la reducción de estancias prolongadas en uci neonatal.


Abstract Objective : To determine the factors associated with prolonged stays in neonatal icu. Materials and Methods : This is a retrospective, cross-sectional, descriptive and analytical study based on the Individual Service Delivery Registries (RIPS) and the billing of a Health Services Provider Company (EPS) of Colombia. A binomial logistic model was estimated using prolonged stays as a dependent variable. Results : The median length of stay in the icu of the 947 neonates included in the analysis was three days with an average sojourn of 4.8 days (interquartile range of 1-5 days). Regarding the determinants: gestational age, birth weight and age of the mother, they have an inverse relationship with the probability of ge nerating stays, while living in urban areas and having accurate prenatal control become protective factors. Conclusion : Prenatal control is an efficient and effective intervention for managing health risk, also reducing pregnancies in young (<18 years) and older women (> 35 years) would play a key role in decreasing prolonged stays in neonatal icu.


Resumo Objetivo : determinar os fatores associados a estadias prolongadas na uci neonatal. Materiais e métodos : estudo de tipo retrospectivo, de corte transversal, descritivo e analítico a partir dos Registros Individuais de prestação de serviços (RIPS) e a faturação de uma Empresa Prestadora de Serviços de Saúde (EPS) da Colômbia. Se estimou um modelo logístico binomial tomando como variável dependente estadias pro longadas. Resultados : a mediana da duração em estadias na uci dos 947 neonatos incluídos na análise foi de 3 dias e uma estadia média de 4.8 dias (amplitude interquartílica de 1-5 dias). Respeito aos deter minantes, a idade gestacional, o peso ao nascer e a idade da mãe mantêm uma relação inversa com a probabilidade de gerar dias estadias, residir em zonas urbanas e contar com um bom controle pré-natal tornam-se em fatores protetores. Conclusão : o controle pré-natal é uma intervenção eficiente e efetiva para a gestão do risco da saúde, assim como diminuir as gravidezes nas mulheres jovens (<18 anos) e maiores (>35 anos) teriam um papel fundamental na redução de estadias prolongadas na uci neonatal.


Asunto(s)
Humanos , Recién Nacido , Recién Nacido , Atención Prenatal , Unidades de Cuidado Intensivo Neonatal , Hospitalización
4.
Rev. salud pública ; Rev. salud pública;20(5): 591-598, oct.-nov. 2018. tab
Artículo en Español | LILACS | ID: biblio-1004474

RESUMEN

RESUMEN Objetivo Estimar el gasto de bolsillo y la probabilidad de gasto catastrófico de los hogares y sus determinantes socioeconómicos en Cartagena, Colombia. Materiales y Métodos Estudio transversal en una muestra poblacional estratificada aleatoria de hogares de Cartagena. Se estimaron dos modelos de regresión cuyas variables dependientes fueron gasto de bolsillo y probabilidad de gasto catastrófico en salud de los hogares. Resultados El gasto de bolsillo promedio anual en hogares pobres fue 1 566 036 COP (US$783) (IC95% 1 117 597-2 014 475); en hogares de estrato medio 2 492 928 COP (US$1246) (IC95% 1 695 845-3 290 011) y en hogares ricos 4 577 172 COP (US$2 288) (IC95% 1 838 222-7 316 122). Como proporción del ingreso, el gasto de bolsillo en salud fue de 14,6% en los hogares pobres, de 8,2% en los hogares de estrato medio y de 7,0% en los hogares ricos. La probabilidad de gasto catastrófico en salud de los hogares pobres fue 30,6% (IC95% 25,6-35,5%), de los de estrato medio del 10,2% (IC95% 4,5-15,9%) y de los hogares de estrato alto del 8,6% (IC95% 1,823,0%). El estrato socioeconómico, la educación y la ocupación fueron los principales determinantes del gasto de bolsillo en salud y de la probabilidad de incurrir en gasto catastrófico en salud. Conclusiones En el sistema de salud persisten desigualdades en la protección financiera de los hogares contra el gasto de bolsillo y la probabilidad de gasto catastrófico. El presente estudio genera evidencia para revisar la política de protección social de los hogares socioeconómicamente más vulnerables.(AU)


ABSTRACT Objective To estimate out-of-pocket (OOP) health expenditure and the probability to incur in catastrophic health expenditure, as well as the socio-demographic determinants of households in Cartagena, Colombia. Materials and Methods Population-based cross-sectional study on a randomized stratified sample of Cartagena households. Two regression models were developed using OOP health expenditure and the probability to incur in catastrophic health expenditure as dependent variables. Results The average annual OOP health expenditure was $1 566 036 COP (US$783) (95%CI: $1 117 597 - $2 014 475) in poor households, $2 492 928 COP (US$1 246) (95%CI: $1 695 845 - $3 290 011) in middle class households, and $4 577 172 COP (uS$2 288) (95%CI: $1 838 222 - $7 316 122) in upper class households. Regarding the household income ratio, the OOP health expenditure was 14.6% in poor households, 8.2% in middle class, and 7.0% in upper class households. The probability to incur in catastrophic health expenditure was 30.6% (95%CI: 25.6% - 35.5%), 10.2% (95%CI: 4.5%-15.9%) and 8.6% (95%CI: 1.8%-23%) in the low, middle- and high-class households, respectively. Educational attainment, socioeconomic strata and employment were the main determinants of OOP and the probability to incur in catastrophic health expenditure. Conclusions The health system has persistent inequalities regarding the financial protection of households related to out-of-pocket expenditure and the probability of catastrophic expenditure. This study provides evidence to review the social protection policy for the most socio-economically vulnerable households.(AU)


Asunto(s)
Humanos , Salud de la Familia/economía , Gastos en Salud , Equidad en Salud , Factores Socioeconómicos , Estudios Transversales/instrumentación , Colombia
5.
Rev Salud Publica (Bogota) ; 20(5): 591-598, 2018.
Artículo en Español | MEDLINE | ID: mdl-33111892

RESUMEN

OBJECTIVE: To estimate out-of-pocket (OOP) health expenditure and the probability to incur in catastrophic health expenditure, as well as the socio-demographic determinants of households in Cartagena, Colombia. MATERIALS AND METHODS: Population-based cross-sectional study on a randomized stratified sample of Cartagena households. Two regression models were developed using OOP health expenditure and the probability to incur in catastrophic health expenditure as dependent variables. RESULTS: The average annual OOP health expenditure was $1 566 036 COP (US$783) (95%CI: $1 117 597 - $2 014 475) in poor households, $2 492 928 COP (US$1 246) (95%CI: $1 695 845 - $3 290 011) in middle class households, and $4 577 172 COP (uS$2 288) (95%CI: $1 838 222 - $7 316 122) in upper class households. Regarding the household income ratio, the OOP health expenditure was 14.6% in poor households, 8.2% in middle class, and 7.0% in upper class households. The probability to incur in catastrophic health expenditure was 30.6% (95%CI: 25.6% - 35.5%), 10.2% (95%CI: 4.5%-15.9%) and 8.6% (95%CI: 1.8%-23%) in the low, middle- and high-class households, respectively. Educational attainment, socioeconomic strata and employment were the main determinants of OOP and the probability to incur in catastrophic health expenditure. CONCLUSIONS: The health system has persistent inequalities regarding the financial protection of households related to out-of-pocket expenditure and the probability of catastrophic expenditure. This study provides evidence to review the social protection policy for the most socio-economically vulnerable households.


OBJETIVO: Estimar el gasto de bolsillo y la probabilidad de gasto catastrófico de los hogares y sus determinantes socioeconómicos en Cartagena, Colombia. MATERIALES Y MÉTODOS: Estudio transversal en una muestra poblacional estratificada aleatoria de hogares de Cartagena. Se estimaron dos modelos de regresión cuyas variables dependientes fueron gasto de bolsillo y probabilidad de gasto catastrófico en salud de los hogares. RESULTADOS: El gasto de bolsillo promedio anual en hogares pobres fue 1 566 036 COP (US$783) (IC95% 1 117 597-2 014 475); en hogares de estrato medio 2 492 928 COP (US$1246) (IC95% 1 695 845-3 290 011) y en hogares ricos 4 577 172 COP (US$2 288) (IC95% 1 838 222-7 316 122). Como proporción del ingreso, el gasto de bolsillo en salud fue de 14,6% en los hogares pobres, de 8,2% en los hogares de estrato medio y de 7,0% en los hogares ricos. La probabilidad de gasto catastrófico en salud de los hogares pobres fue 30,6% (IC95% 25,6-35,5%), de los de estrato medio del 10,2% (IC95% 4,5-15,9%) y de los hogares de estrato alto del 8,6% (IC95% 1,823,0%). El estrato socioeconómico, la educación y la ocupación fueron los principales determinantes del gasto de bolsillo en salud y de la probabilidad de incurrir en gasto catastrófico en salud. CONCLUSIONES: En el sistema de salud persisten desigualdades en la protección financiera de los hogares contra el gasto de bolsillo y la probabilidad de gasto catastrófico. El presente estudio genera evidencia para revisar la política de protección social de los hogares socioeconómicamente más vulnerables.

6.
Salud Publica Mex ; 59(2): 176-182, 2017.
Artículo en Español | MEDLINE | ID: mdl-28562718

RESUMEN

OBJECTIVE:: To estimate health care costs of live births and the impact of prenatal care visit (PCV) in women from poor households. MATERIALS AND METHODS:: A randomized sample of 9 244 pregnant women (out of total= 25 000). Mean differences and proportions were calculated to compare results in both groups of women. The costs were estimated in American Dollars (USD) 2014, from the payer's perspective. RESULTS:: 75% of women live in urban areas. The mean age was 23 years old (CI95% 23.5-23.8). The average cost with PCV was USD 609.1 (CI95%: 581-632.7) and without PCV was USD 857.8 (CI95%: 774.7-923.8) and 87% of women attended at least one PCV. The health care costs increased in 32% (CI95% 27.1-41) in women who did not attended PCV. CONCLUSION:: The PCV is an efficient and effective intervention for managing the risk of maternal health.


Asunto(s)
Seguro de Salud , Atención Prenatal , Adulto , Colombia , Control de Costos , Estudios Transversales , Femenino , Costos de la Atención en Salud , Humanos , Mortalidad Materna , Pobreza , Embarazo , Atención Prenatal/economía , Salud Pública/economía , Muestreo , Factores Socioeconómicos , Población Urbana , Adulto Joven
7.
Salud pública Méx ; 59(2): 176-182, mar.-abr. 2017. tab
Artículo en Español | LILACS | ID: biblio-846073

RESUMEN

Resumen: Objetivo: Analizar el impacto sanitario y económico del control prenatal (CPN) en mujeres de hogares pobres. Material y métodos: Se tomó una muestra aleatoria de 9 244 mujeres embarazadas (población= 25 000). Se estimó la incidencia de mortalidad materna, los costos directos de atención y la diferencia de medias y proporciones. Los costos fueron estimados en dólares americanos (USD) de 2014, con perspectiva del tercer pagador. Resultados: El 75% de las mujeres viven en zonas urbanas. La media de edad fue de 23 años (IC95%: 23.5-23.8). El 87.5% asistió al menos a una cita de CPN. El costo medio de partos con CPN fue de USD$ 609.1 (IC95%: 581-632.7). Sin CPN fue de USD $857.8 (IC95%: 774.7-923.8). Los costos se incrementan 32% (IC95% 27.1-41) sin CPN. Conclusión: El CPN es una intervención eficiente y efectiva para la gestión del riesgo de la salud materna.


Abstract: Objective: To estimate health care costs of live births and the impact of prenatal care visit (PCV) in women from poor households. Materials and methods: A randomized sample of 9 244 pregnant women (out of total= 25 000). Mean differences and proportions were calculated to compare results in both groups of women. The costs were estimated in American Dollars (USD) 2014, from the payer’s perspective. Results: 75% of women live in urban areas. The mean age was 23 years old (CI95% 23.5-23.8). The average cost with PCV was USD 609.1 (CI95%: 581-632.7) and without PCV was USD 857.8 (CI95%: 774.7-923.8) and 87% of women attended at least one PCV. The health care costs increased in 32% (CI95% 27.1-41) in women who did not attended PCV. Conclusion: The PCV is an efficient and effective intervention for managing the risk of maternal health.


Asunto(s)
Humanos , Femenino , Embarazo , Adulto , Adulto Joven , Atención Prenatal/economía , Seguro de Salud , Pobreza , Factores Socioeconómicos , Población Urbana , Mortalidad Materna , Salud Pública/economía , Estudios Transversales , Muestreo , Costos de la Atención en Salud , Colombia , Control de Costos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA